An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of PA-111 in Healthy Adult Volunteers
Latest Information Update: 23 May 2025
At a glance
- Drugs PA 111 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Addpharma
Most Recent Events
- 23 May 2025 New trial record